5th mRNA-Based Therapeutics Summit Europe.

Meet RNAlead at the 5th mRNA-Based Therapeutics Summit, 27th – 29th January 2026 | Berlin, Germany

RNAlead will attend the next mRNA-Based Therapeutics Summit in Berlin, Germany.

The 5th mRNA-Based Therapeutics Summit Europe is the ultimate biopharma platform diving into novel mRNA, sa-RNA and circular RNA design to delivery innovations, giving you the latest insights and connections to turn these breakthroughs into action. Enhanced with the brand-new Gene Editing Focus Day to harness mRNA’s power through transient editing strategies, and Investor-Led sessions on what makes an mRNA platform fundable in 2026, leave this meeting with tried and tested strategies to de-risk your programs and secure partnerships in today’s competitive landscape.

This interactive meeting unites global leaders in mRNA R&D, CMC, Regulatory Affairs, Clinical Development, and Business Strategy to address the field’s toughest challenges: broadening mRNA’s scope beyond vaccines, unlocking targeted and tissue-specific delivery, overcoming CMC and stability hurdles in saRNA and circRNA, and restoring investor confidence in RNA’s therapeutic promise.

Alongside the brand-new Gene Editing Focus Day, key sessions will uncover the next-generation delivery systems (targeted LNPs, polymerics, and VLPs), chemically synthesised mRNA, manufacturing innovation, integration of AI into mRNA design, and translational strategies to bring novel RNA products into the clinic with speed, safety, and scalability.

If you’re attending the event, we would be delighted to meet you there ! Please contact us using our online contact form to schedule a meeting.

We look forward to seeing you in Berlin and discussing how RNAlead can support your projects, from early-stage research to clinical applications.